Events Partner Content 2019 Indegene Digital Summit - From Blockbuster Drugs to Blo... First-of-its-kind summit for Pharma & Biotech
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
